Men treated with androgen-deprivation therapy for advanced prostate cancer appear to be at risk for cognitive decline within 6 months of starting ther... More »
Aromatase inhibitor-induced arthralgia substantially improved in women who received omega-3 fatty acid capsules, as well as in those who took placebo,... More »
Aromatase inhibitor-induced arthralgia substantially improved in women who received omega-3 fatty acid capsules, as well as in those who took placebo,... More »
Vigorous physical activity may help lower the risk of non-Hodgkin’s lymphoma, Terry Boyle, Ph.D., and his coauthors reported in Cancer Epidemiology,... More »
Lung cancer patients who used statins in the year before being diagnosed with lung cancer had a 12% reduction in lung cancer-specific deaths (adjusted... More »
A new agent targeting tumors that develop resistance to EGFR tyrosine kinase inhibitors proved to be “highly active” in a phase I clinical trial i... More »
Rociletinib, a third-generation EGFR tyrosine kinase inhibitor that targets mutations causing treatment resistance, showed sustained activity against ... More »
A phase II study evaluating single-agent olaparib in metastatic, castration-resistant prostate cancer offers the first evidence that genetic testing c... More »
VIENNA– In addition to dramatically increasing the risk of liver cancer more than 68-fold, chronic hepatitis C virus (HCV) infection more than doubl... More »
VIENNA– In addition to dramatically increasing the risk of liver cancer more than 68-fold, chronic hepatitis C virus (HCV) infection more than doubl... More »